Correlation Engine 2.0
Clear Search sequence regions


To investigate the feasibility of high-dose dobutamine stress (HDDS) imaging using SSFP sequences at 3 T employing patient-adaptive local RF-shimming using a dual-source RF transmission system. 13 Patients underwent a HDDS protocol on a 3 T MRI scanner (Achieva 3.0T-TX, Philips Healthcare), equipped with a dual-source RF transmission system. SSFP cine sequences using patient-adaptive local RF-shimming (RF-S) were compared to cine images acquired without additional shimming. Image quality was evaluated on a 4-point grading scale and number of non-diagnostic segments assessed. Contrast (CN) between myocardium (SIM) and blood pool (SIB) was calculated [(SIB-SIM)/(SIB+SIM)]. Image quality both at rest and maximum stress was significantly improved with RF-S (ED:3.56±0.5 vs. 3.23±0.63; ES:3.4±0.5 vs. 3.1±0.7) compared to no RF-S (ED:2.9±0.72 vs. 2.15±0.78; ES:2.64±0.74 vs. 1.95±0.76; p<0.01). The amount of non-diagnostic segments was significantly reduced when using RF-S at rest and stress (3 vs. 39; 19 vs. 78, p<0.05). All HDDS studies were diagnostic if performed with RF-S (n=13/13) in comparison to conventional shimming (n=5/13). Image contrast was improved for SSFP sequences with RF-S (0.53±0.08) compared to conventional images (0.46±0.09, p=0.06). Patient-adaptive local RF-shimming using a dual-source RF transmission system allows for reliable SSFP imaging in a clinical high-dose dobutamine stress protocol at 3 T. RF-S significantly improves image quality and reduces the number of non-diagnostic myocardial segments. © Georg Thieme Verlag KG Stuttgart · New York.

Citation

K Strach, R Clauberg, A Müller, U Wonneberger, C P Naehle, M Kouwenhoven, J Gieseke, H H Schild, D Thomas. Feasibility of high-dose dobutamine stress SSFP Cine MRI at 3 Tesla with patient adaptive local RF Shimming using dual-source RF transmission: initial results. RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 2013 Jan;185(1):34-9

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23129459

View Full Text